Anchor Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-8,700
| Closed | -$400K | – | 296 |
|
|
2016
Q3 | $400K | Sell |
8,700
-11,610
| -57% | -$534K | 0.01% | 224 |
|
|
2016
Q2 | $1.02M | Sell |
20,310
-14,753
| -42% | -$741K | 0.03% | 166 |
|
|
2016
Q1 | $1.88M | Sell |
35,063
-4,852
| -12% | -$260K | 0.05% | 137 |
|
|
2015
Q4 | $2.62M | Sell |
39,915
-846
| -2% | -$55.5K | 0.07% | 137 |
|
|
2015
Q3 | $2.3M | Hold |
40,761
| – | – | 0.06% | 136 |
|
|
2015
Q2 | $2.41M | Sell |
40,761
-762
| -2% | -$45K | 0.05% | 141 |
|
|
2015
Q1 | $2.59M | Buy |
41,523
+2,290
| +6% | +$143K | 0.06% | 143 |
|
|
2014
Q4 | $2.26M | Buy |
39,233
+14,774
| +60% | +$850K | 0.05% | 153 |
|
|
2014
Q3 | $1.32M | Sell |
24,459
-7,981
| -25% | -$429K | 0.03% | 181 |
|
|
2014
Q2 | $1.7M | Buy |
32,440
+15,358
| +90% | +$805K | 0.03% | 164 |
|
|
2014
Q1 | $903K | Sell |
17,082
-642
| -4% | -$33.9K | 0.02% | 201 |
|
|
2013
Q4 | $710K | Sell |
17,724
-3,006
| -15% | -$120K | 0.01% | 219 |
|
|
2013
Q3 | $783K | Buy |
20,730
+6
| +0% | +$227 | 0.02% | 193 |
|
|
2013
Q2 | $812K | Buy |
+20,724
| New | +$812K | 0.02% | 190 |
|